Illumina Inc. (ILU)
XDUS
Closed
Oct 19, 2026
Day's Range
234.0052 wk Range
81.54Overview - ILU - Illumina Inc.
Key Statistics
Valuation
Enterprise Value
1.13B
P/E (Trailing)
‪44.52‬
PEG Ratio
‪-5.52‬
EV / EBITDA
‪0.77‬
Profitability
Profit Margin
‪66.08%‬
Operating Margin
‪27.33%‬
Return on Assets
‪12.79%‬
Return on Equity
‪31.21%‬
Ownership
Shares Outstanding
151.00M
Price stats
50-Day Avg
‪189.66‬
200-Day Avg
‪140.50‬
Peers - ILU - Illumina Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XDUS.
- ILUXDUSIllumina, Inc.+65.36%52-week change44.52P/E (Trailing)‪66.08%‬Profit Margin
- NL0XDUSGRAIL, Inc.+53.52%52-week change-10.50P/E (Trailing)‪-236.94%‬Profit Margin
- 0MEXDUSTwist Bioscience Corporation+80.08%52-week change-108.42P/E (Trailing)‪50.72%‬Profit Margin
- 1K9XDUSCareDx, Inc.+77.16%52-week change-137.50P/E (Trailing)‪67.55%‬Profit Margin
- 5GHXDUSGuardant Health Inc.+64.22%52-week change-45.10P/E (Trailing)‪64.46%‬Profit Margin
- 1HMXDUSAdaptive Biotechnologies Corporation Common Stock+52.26%52-week change-64.18P/E (Trailing)‪74.23%‬Profit Margin
- 04XXDUSPersonalis Inc.+51.53%52-week change-15.62P/E (Trailing)‪22.65%‬Profit Margin
Profile Summary - ILU - Illumina Inc.
About
Illumina, Inc. is a life sciences and diagnostics company that develops, manufactures, and markets tools and integrated systems for the analysis of genetic material. Its primary focus is on next-generation sequencing technologies, providing high-throughput and lower-throughput sequencing instruments, consumables, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
